OBJECTIVES: The aim of this study was to understand the strengths and limitations of
current prevention, detection, and screening methods for ovarian cancer and to identify …

The majority of women with ovarian cancer present with advanced-stage disease. Women
with early-stage ovarian cancer have a much better chance of achieving a cure than do …

Abstract In 2005, more than 22,000 American women were diagnosed with ovarian cancer
and 16,000 women died from the disease. The five-year relative survival rate for stage III and …

BRCA 1 and BRCA 2 mutation carriers have an 18%–60% and 11%–27% lifetime risk of
developing ovarian carcinoma, respectively. Prophylactic bilateral salpingo-oophorectomy …

In 1994 the US National Institutes of Health convened a consensus conference for the
management of ovarian cancer. 1 At that time, the recommendation was to obtain a family …

Approximately 20,000 women are diagnosed with ovarian cancer in the United States each
year, and some 12,000 women die because of it. Epithelial ovarian cancer, the most …

Objective The aim of this study is to provide a summary report on recent research advances
in ovarian cancer prevention, screening, and early detection that were presented at the 11th …

Ovarian cancer is difficult to manage because the disease is most often diagnosed at an
advanced stage when survival chances are poor. Early detection of ovarian cancer would …

Epithelial ovarian cancer is the most lethal of the gynecologic malignancies, largely due to
the advanced stage at diagnosis in most patients. Screening strategies using ultrasound and …

Randomized controlled trials are now under way in the general population to examine many
of these issues and assess the impact of screening on ovarian cancer mortality. The United …